MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.arbres.2026.05.016

Медицинская библиотека · Archivos de bronconeumologia · 2026

Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).

Candal-Pedreira Cristina, Ruano-Ravina Alberto, Calvo de Juan Virginia, Cobo Manuel, Cantero Alexandra, Rodríguez-Abreu Delvys, Estival Anna, Carcereny Enric, Hernandez Ainhoa, López Castro Rafael, Medina Andrea, García Campelo Rosario, Fernández Bruno Manuel, Bernabé Reyes, Bosch-Barrera Joaquim, Massutí Bartomeu, Dómine Manuel, Camps Carlos, Ortega Ana Laura, Provencio Mariano

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Small cell lung cancer (SCLC) represents approximately 15% of all lung cancers and is characterized by poor survival. This study describes SCLC cases diagnosed in Spain and analyzes differences in patient characteristics and outcomes according to tobacco use.

METHODS

A cross-sectional study was conducted using data from the Thoracic Tumor Registry of the Grupo Español de Cáncer de Pulmón. All SCLC cases diagnosed between 2016 and 2025 were included. Sociodemographic and clinical variables were described and compared according to tobacco use (never smoker, former smoker, current smoker) and sex. Survival was assessed using Kaplan-Meier curves and multivariable Cox regression models.

RESULTS

A total of 4920 cases were analyzed: 91 never smokers (1.8%), 1872 former smokers (38.1%), and 2957 current smokers (60.1%). Men accounted for 78.9% of cases, and the median age was 66 years. At diagnosis, 68.2% of patients had extensive-stage SCLC. Current smokers were more frequently female and younger. The most common symptoms were cough (36.7%) and dyspnea (36.0%). Five-year survival was 9.4% (95%CI, 8.3-10.5): 15.4% in never smokers, 10.8% in former smokers, and 8.2% in current smokers. Survival was higher in women than in men regardless of tobacco use. Higher mortality was associated with male sex (HR, 1.10; 95%CI, 1.01-1.20), current smoking (HR, 1.30; 95%CI, 1.01-1.68), older age (HR, 1.03 per year; 95%CI, 1.02-1.03), and extensive-stage disease (HR, 2.96; 95%CI, 2.72-3.22).

CONCLUSIONS

The clinical characteristics and survival outcomes of SCLC differ according to tobacco use and sex. Current smokers have a poorer prognosis than never smokers, and women have higher survival across all groups.

Для цитирования: Candal-Pedreira Cristina, Ruano-Ravina Alberto, Calvo de Juan Virginia, Cobo Manuel, Cantero Alexandra, Rodríguez-Abreu Delvys, Estival Anna, Carcereny Enric, Hernandez Ainhoa, López Castro Rafael, Medina Andrea, García Campelo Rosario, Fernández Bruno Manuel, Bernabé Reyes, Bosch-Barrera Joaquim, Massutí Bartomeu, Dómine Manuel, Camps Carlos, Ortega Ana Laura, Provencio Mariano. Clinical Characteristics and Survival Outcomes in Patients With Small Cell Lung Cancer in Spain: An Analysis of the Thoracic Tumor Registry (2016-2025).. Archivos de bronconeumologia. 2026. DOI: 10.1016/j.arbres.2026.05.016.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.